Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Genetics
|
April 1, 1979
Cytogamy: An Inducible, Alternate Pathway of Conjugation in TETRAHYMENA THERMOPHILA
E Orias, E P Hamilton
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1988
Three binding sites for AraC protein are required for autoregulation of araC in Escherichia coli
E P Hamilton, N Lee
Science (New York, N.Y.)
|
February 16, 1979
Osmotic shock prevents nuclear exchange and produces whole-genome homozygotes in conjugating Tetrahymena
E Orias, E P Hamilton, M Flacks
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1987
Arabinose-induced binding of AraC protein to araI2 activates the araBAD operon promoter
N Lee, C Francklyn, E P Hamilton
Science (New York, N.Y.)
|
October 14, 1983
A microtubule meshwork associated with gametic pronucleus transfer across a cell-cell junction
J D Orias, E P Hamilton, E Orias
Journal of Bacteriology
|
February 1, 1987
Repression and catabolite gene activation in the araBAD operon
H S Lichenstein, E P Hamilton, N Lee
Genetics
|
April 1, 1988
Pronuclear fusion failure: an alternate conjugational pathway in Tetrahymena thermophila, induced by vinblastine
E P Hamilton, P B Suhr-Jessen, E Orias
Genetics
|
July 6, 2000
Autonomously replicating macronuclear DNA pieces are the physical basis of genetic coassortment groups in Tetrahymena thermophila
L Wong, L Klionsky, S Wickert, et al.
ESMO Open
|
November 26, 2025
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
S Kuemmel, K H Jung, L Andrade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
S Banerjee, A M Oza, M J Birrer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Genetics
|
April 1, 1979
Cytogamy: An Inducible, Alternate Pathway of Conjugation in TETRAHYMENA THERMOPHILA
E Orias, E P Hamilton
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1988
Three binding sites for AraC protein are required for autoregulation of araC in Escherichia coli
E P Hamilton, N Lee
Science (New York, N.Y.)
|
February 16, 1979
Osmotic shock prevents nuclear exchange and produces whole-genome homozygotes in conjugating Tetrahymena
E Orias, E P Hamilton, M Flacks
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1987
Arabinose-induced binding of AraC protein to araI2 activates the araBAD operon promoter
N Lee, C Francklyn, E P Hamilton
Science (New York, N.Y.)
|
October 14, 1983
A microtubule meshwork associated with gametic pronucleus transfer across a cell-cell junction
J D Orias, E P Hamilton, E Orias
Journal of Bacteriology
|
February 1, 1987
Repression and catabolite gene activation in the araBAD operon
H S Lichenstein, E P Hamilton, N Lee
Genetics
|
April 1, 1988
Pronuclear fusion failure: an alternate conjugational pathway in Tetrahymena thermophila, induced by vinblastine
E P Hamilton, P B Suhr-Jessen, E Orias
Genetics
|
July 6, 2000
Autonomously replicating macronuclear DNA pieces are the physical basis of genetic coassortment groups in Tetrahymena thermophila
L Wong, L Klionsky, S Wickert, et al.
ESMO Open
|
November 26, 2025
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
S Kuemmel, K H Jung, L Andrade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
S Banerjee, A M Oza, M J Birrer, et al.
Page
of 2